BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35462067)

  • 21. Anti-apoptotic actions of the platelet-activating factor acetylhydrolase I alpha2 catalytic subunit.
    Bonin F; Ryan SD; Migahed L; Mo F; Lallier J; Franks DJ; Arai H; Bennett SA
    J Biol Chem; 2004 Dec; 279(50):52425-36. PubMed ID: 15456758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of maternal plasma platelet activating factor acetylhydrolase activity and mRNA expression in pre-eclampsia: a case control study.
    Gupta P; Agarwal R; Bhaskaran S; Garg S; Mehndiratta M; Radhakrishnan G; Singh A; Agarwal R; Narang D
    J Obstet Gynaecol; 2021 Jul; 41(5):726-732. PubMed ID: 33073639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin hydrolysis in plasma is a variable function of butyrylcholinesterase and platelet-activating factor acetylhydrolase 1b2 (PAFAH1b2).
    Zhou G; Marathe GK; Hartiala J; Hazen SL; Allayee H; Tang WH; McIntyre TM
    J Biol Chem; 2013 Apr; 288(17):11940-8. PubMed ID: 23508960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-activating factor inactivation by local expression of platelet-activating factor acetyl-hydrolase modifies tumor vascularization and growth.
    Biancone L; Cantaluppi V; Del Sorbo L; Russo S; Tjoelker LW; Camussi G
    Clin Cancer Res; 2003 Sep; 9(11):4214-20. PubMed ID: 14519648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery.
    Tsoukatos DC; Brochériou I; Moussis V; Panopoulou CP; Christofidou ED; Koussissis S; Sismanidis S; Ninio E; Siminelakis S
    J Lipid Res; 2008 Oct; 49(10):2240-9. PubMed ID: 18587071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil cathepsin G, but not elastase, induces aggregation of MCF-7 mammary carcinoma cells by a protease activity-dependent cell-oriented mechanism.
    Yui S; Osawa Y; Ichisugi T; Morimoto-Kamata R
    Mediators Inflamm; 2014; 2014():971409. PubMed ID: 24803743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-activating factor (PAF) acetylhydrolase activity, LIS1 expression, and seizures.
    Shmueli O; Cahana A; Reiner O
    J Neurosci Res; 1999 Jul; 57(2):176-84. PubMed ID: 10398295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis.
    Gill P; Jindal NL; Jagdis A; Vadas P
    J Allergy Clin Immunol; 2015 Jun; 135(6):1424-32. PubMed ID: 26051949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection.
    Caini P; Guerra CT; Giannini C; Giannelli F; Gragnani L; Petrarca A; Solazzo V; Monti M; Laffi G; Zignego AL
    J Viral Hepat; 2007 Jan; 14(1):22-8. PubMed ID: 17212640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.
    Ninio E; Tregouet D; Carrier JL; Stengel D; Bickel C; Perret C; Rupprecht HJ; Cambien F; Blankenberg S; Tiret L
    Hum Mol Genet; 2004 Jul; 13(13):1341-51. PubMed ID: 15115767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
    McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
    Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy.
    Tselepis AD; Goudevenos JA; Tambaki AP; Michalis L; Stroumbis CS; Tsoukatos DC; Elisaf M; Sideris DA
    Cardiovasc Res; 1999 Jul; 43(1):183-91. PubMed ID: 10536703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase.
    Castro Faria Neto HC; Stafforini DM; Prescott SM; Zimmerman GA
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():83-91. PubMed ID: 15962103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles.
    Mitsios JV; Vini MP; Stengel D; Ninio E; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1907-13. PubMed ID: 16728656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis.
    Chen J; Yang L; Foulks JM; Weyrich AS; Marathe GK; McIntyre TM
    J Lipid Res; 2007 Nov; 48(11):2365-76. PubMed ID: 17693621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo.
    Kono N; Inoue T; Yoshida Y; Sato H; Matsusue T; Itabe H; Niki E; Aoki J; Arai H
    J Biol Chem; 2008 Jan; 283(3):1628-1636. PubMed ID: 18024956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor.
    Gao T; Yu Y; Cong Q; Wang Y; Sun M; Yao L; Xu C; Jiang W
    BMC Cancer; 2018 Oct; 18(1):999. PubMed ID: 30340558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase.
    Liu J; Chen R; Marathe GK; Febbraio M; Zou W; McIntyre TM
    Circ Res; 2011 Feb; 108(4):469-77. PubMed ID: 21183738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated Levels of Platelet Activating Factor and Its Acetylhydrolase Indicate High Risk of Kawasaki Disease.
    Yi L; Zhang J; Zhong J; Zheng Y
    J Interferon Cytokine Res; 2020 Mar; 40(3):159-167. PubMed ID: 31841639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Plasma platelet-activating factor acetylhydrolase (PAF-AH) deficiency as a risk factor for stroke].
    Satoh K
    Brain Nerve; 2008 Nov; 60(11):1319-24. PubMed ID: 19069165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.